Material Agreements

GUGGENHEIM STRATEGIC OPPORTUNITIES FUND amended Fourth Amendment to Controlled Equity Offering SM Sales Agreement with Guggenheim Funds Investment Advisors, LLC and Cantor Fitzgerald & Co. valued at up to $850,000,000 (effective 2024-05-03).

“Guggenheim Strategic Opportunities Fund (NYSE: GOF) (the “Fund”) has entered into a Controlled Equity Offering SM Sales Agreement, dated July 1, 2019, as amended by First Amendment to Controlled Equity Offering SM Sales Agreement, dated February 1, 2021, Second Amendment to Controlled Equity Offering SM Sales Agreement, dated September 16, 2021, Third Amendment to Controlled Equity Offering SM Sales Agreement, dated March 27, 2023, and Fourth Amendment to Controlled Equity Offering SM Sales Agreement, dated May 3, 2024 (as amended, the “Sales Agreement”), by and among the Fund, Guggenheim Funds Investment Advisors, LLC, and Cantor Fitzgerald & Co. (“Cantor Fitzgerald”)”

HALLMARK VENTURE GROUP, INC. entered into On Demand Promissory Note Agreement with independent privately-held non-affiliated third party valued at $100,000 (implied 8% interest) (effective 2024-05-02).

“On May 2, 2024, the Company subsequently made a strategic loan with an independent privately-held non-affiliated third party by entering into a 180 day 8% On Demand Promissory Note Agreement.”

HALLMARK VENTURE GROUP, INC. entered into Warrant Subscription Agreement with Nicosel, LLC valued at 100,000 warrants (effective 2024-05-01).

“On May 1, 2024, Hallmark Venture Group, Inc (the “Company”) issued a $100,000, 8% Convertible Promissory Note (the “Note”) and entered into a Warrant Subscription Agreement with Nicosel, LLC , a non-affiliate of the Company.”

HALLMARK VENTURE GROUP, INC. entered into Convertible Promissory Note with Nicosel, LLC valued at $100,000 (effective 2024-05-01).

“On May 1, 2024, Hallmark Venture Group, Inc (the “Company”) issued a $100,000, 8% Convertible Promissory Note (the “Note”) and entered into a Warrant Subscription Agreement with Nicosel, LLC , a non-affiliate of the Company.”

Zumiez Inc terminated Credit Agreement with Wells Fargo Bank, N.A. (effective 2024-05-03).

“Terminated a Credit Agreement between the Company and Wells Fargo Bank, N.A. (the “ Bank ”) originally entered into on December 7, 2018”

ITC Holdings Corp. entered into Eighth Supplemental Indenture with Computershare Trust Company, National Association valued at $400.0 million (effective 2024-05-09).

“On May 9, 2024, ITC Holdings Corp. (the “Company”) entered into an Eighth Supplemental Indenture (the “Eighth Supplemental Indenture”), between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as trustee (the “Trustee”), to the Indenture, dated as of April 18, 2013 (the “Base Indenture” and, as amended and supplemented by the Eighth Supplemental Indenture, the “Indenture”), between the Company and the Trustee, under which the Company issued $400.0 million aggregate principal amount of its 5.650% senior notes due 2034 (the “notes”).”

ABVC BIOPHARMA, INC. entered into Oncox Agreement with OncoX BioPharma, Inc. valued at $6,250,000 (effective 2024-05-08).

“ompany entered into a definitive agreement with OncoX BioPharma, Inc., a private company registered in the British Virgin Islands (“ Oncox ”),”

CENTERPOINT ENERGY INC entered into Supplemental Indenture with The Bank of New York Mellon Trust Company, National Association (successor to JPMorgan Chase Bank, National Association (formerly JPMorgan Chase Bank)), as trustee valued at $700,000,000 (effective 2024-05-10).

“The Notes are being issued pursuant to the Indenture, dated as of May 19, 2003 (the “Base Indenture”), between the Company and The Bank of New York Mellon Trust Company, National Association (successor to JPMorgan Chase Bank, National Association (formerly JPMorgan Chase Bank)), as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. 15 to the Base Indenture to be dated as of May 10, 2024 between the Company and the Trustee (the “Supplemental Indenture”) with respect to the Notes.”

CENTERPOINT ENERGY INC entered into Underwriting Agreement with BNP Paribas Securities Corp., J.P. Morgan Securities LLC, PNC Capital Markets LLC, Scotia Capital (USA) Inc. and Truist Securities, Inc., as representatives of the several Underwriters valued at $700,000,000 (effective 2024-05-08).

“On May 8, 2024, CenterPoint Energy, Inc. (“CenterPoint Energy,” or the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with BNP Paribas Securities Corp., J.P. Morgan Securities LLC, PNC Capital Markets LLC, Scotia Capital (USA) Inc. and Truist Securities, Inc., as representatives of the several Underwriters named in Schedule I to the Underwriting Agreement (the “Underwriters”), relating to the underwritten public offering of $700,000,000 aggregate principal amount of the Company’s 5.40% Senior Notes due 2029 (the “Notes”).”

RxSight, Inc. entered into Underwriting Agreement with BofA Securities, Inc., as representative of the several underwriters listed in Schedule 1 thereto (the "Underwriters") valued at approximately $93.2 million (effective 2024-05-08).

“On May 8, 2024, RxSight, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., as representative of the several underwriters listed in Schedule 1 thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell 1,785,714 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”).”

PLUS THERAPEUTICS, INC. amended Securities Purchase Agreement with certain investors identified on the signature page thereto (collectively, the "Purchasers") valued at approximately $0.75 million (effective 2024-05-08).

“On May 8, 2024, the Company entered into an amendment to the Securities Purchase Agreement (the “Amendment”) that increased the aggregate subscription amount by approximately $0.75 million (the “Additional Subscription”) for aggregate initial gross proceeds of approximately $7.25 million.”

PLUS THERAPEUTICS, INC. entered into Securities Purchase Agreement with certain investors identified on the signature page thereto (collectively, the "Purchasers") valued at approximately $6.5 million (effective 2024-05-05).

“On May 5, 2024, Plus Therapeutics, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors identified on the signature page thereto (collectively, the “Purchasers”) for a private placement of securities (the “Initial Subscription”) for gross proceeds at the Closing Date (as defined below) of approximately $6.5 million.”

OLENOX INDUSTRIES INC. entered into Securities Purchase Agreement with a single accredited institutional investor valued at approximately $4.0 million (effective 2024-05-03).

“On May 3, 2024, Safe & Green Holdings Corp. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) for a private placement (the “Private Placement”) with a single accredited institutional investor (the “Purchaser”).”

GENESIS ENERGY LP entered into Underwriting Agreement with RBC Capital Markets, LLC, as representative of a group of underwriters named in the Underwriting Agreement valued at $700 million (effective 2024-05-06).

“On May 6, 2024, Genesis Energy, L.P. (“ Genesis ”), Genesis Energy Finance Corporation (together with Genesis, the “ Issuers ”) and certain subsidiary guarantors of Genesis entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with RBC Capital Markets, LLC, as representative of a group of underwriters named in the Underwriting Agreement, in connection with the Issuers’ public offering of senior notes (the “ Offering ”).”

Pacira BioSciences, Inc. amended First TLA Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders (effective 2024-05-08).

“On May 8, 2024, Pacira BioSciences, Inc. (the “Company”), JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders entered into a first amendment (the “First TLA Amendment”) to the Credit Agreement, dated as of March 31, 2023”

VAIL RESORTS INC entered into Indenture with U.S. Bank Trust Company, National Association, as Trustee valued at $600 million (effective 2024-05-08).

“The Notes were issued under an Indenture dated as of May 8, 2024 (the “Indenture”) among the Company, the Guarantors and U.S. Bank Trust Company, National Association, as Trustee.”

ATMOS ENERGY CORP entered into Equity Distribution Agreement with Managers and Forward Purchasers named in Schedule A valued at up to $1,000,000,000 (effective 2024-05-08).

“On May 8, 2024, Atmos Energy Corporation (“Atmos Energy”) entered into an equity distribution agreement (the “Equity Distribution Agreement”) with the Managers (the “Managers”) and Forward Purchasers (the “Forward Purchasers”) named in Schedule A thereto and with respect to the offering and sale from time to time through the Managers, as Atmos Energy’s sales agents, of shares of Atmos Energy’s common stock, no par value, having an aggregate offering price of up to $1,000,000,000 (including shares of common stock that may be sold pursuant to the forward sale agreements described below, the “Shares”).”

SELECTIS HEALTH, INC. entered into Purchase and Sale Agreement with Bibb County Holdings II, LLC valued at Six Million Seven Hundred Fifty Thousand Dollars ($6,750,000) (effective 2024-05-01).

“On May 1, 2024, Selectis Health, Inc., a Utah corporation (the “ Company ”) caused its wholly-owned subsidiary Goodwill Hunting, LLC, a Georgia limited liability company (“ Seller ”) to execute and deliver a definitive Purchase and Sale Agreement (“ PSA ”) with Bibb County Holdings II, LLC, a Georgia limited liability company (“ Purchaser ”); pursuant to which the Seller agreed to sell certain real property located in Macon, Bibb County, Georgia identified as Bibb County Tax Parcels P1030040, P1030254, P1030253, P1030043, P1030052, and P1030252 including that certain skilled nursing facility known as “Archway Transitional Care Center” located at 4373 Houston Avenue, Macon, Bibb County, 31206 (the “Archway Property”).”

Anixa Biosciences Inc entered into Joint Development and Option Agreement with Cleveland Clinic Foundation valued at Company will pay CCF a non-refundable, option fee on or before May 23, 2024, and development funding (effective 2024-05-03).

“On May 3, 2024, Anixa Biosciences, Inc. (the “ Company ”) and the Cleveland Clinic Foundation (the “ CCF ”) entered into a Joint Development and Option Agreement (the “ Agreement ”). Pursuant to the Agreement, the parties agreed on the terms and conditions under which the parties will collaborate in efforts to develop vaccines for the prevention or treatment of cancers in the Fields.”

BBCMS Mortgage Trust 2024-5C25 entered into Pooling and Servicing Agreement with Barclays Commercial Mortgage Securities LLC; Midland Loan Services, a Division of PNC Bank, National Association; 3650 REIT Loan Servicing LLC; Computershare Trust Company, National Association; Pentalpha Lender Surveillance LLC valued at Pooling and Servicing Agreement dated as of March 1, 2024 among the Depositor, master servicer, spec (effective 2024-03-01).

“On March 28, 2024, Barclays Commercial Mortgage Securities LLC (the “ Depositor ”) caused the issuance of the BBCMS Mortgage Trust 2024-5C25, Commercial Mortgage Pass-Through Certificates, Series 2024-5C25 (the “ Certificates ”), pursuant to a pooling and servicing agreement, dated and effective as of March 1, 2024 (the “ Pooling and Servicing Agreement ”), among the Depositor, as depositor, Midland Loan Services, a Division of PNC Bank, National Association, as master servicer, 3650 REIT Loan Servicing LLC, as special servicer, Computershare Trust Company, National Association, as certificate administrator and as trustee, and Pentalpha Lender Surveillance LLC, as operating advisor and as asset representations reviewer.”

ProSomnus, Inc. entered into Restructuring Support Agreement with Sponsoring Noteholders valued at $20.0 million (effective 2024-05-07).

“On May 7, 2024, ProSomnus, Inc. (the “Company”) voluntarily entered into a Restructuring Support Agreement (including all exhibits thereto, collectively, the “RSA”) with (i) certain of its existing affiliates and subsidiaries (as set forth in the RSA, and together with the Company, the “Company Parties”); and (ii) certain sponsoring Senior Noteholders and Subordinated Noteholders (the “Sponsoring Noteholders”).”

T Series Middle Market Loan Fund LLC amended Fifth Amendment with Commonwealth Bank of Australia valued at decrease the Maximum Commitment in the amount of $63,500,000 for an aggregate Maximum Commitment of (effective 2024-05-02).

“On May 2, 2024, T Series Middle Market Loan Fund LLC (the “Company”), a Delaware limited liability company, entered into an amendment (the “Fifth Amendment”) to that certain Revolving Credit Agreement, dated as of November 5, 2021 (as amended, restated or otherwise modified from time to time, the “CBA Subscription Facility”), by and among the Company, as Borrower, and Commonwealth Bank of Australia, as Administrative Agent, Lead Arranger, Letter of Credit Issuer and a Lender.”

Ivanhoe Electric Inc. entered into Exploration Alliance Agreement with BHP Mineral Resources Inc. valued at initial funding of $15 million (effective 2024-05-07).

“On May 7, 2024, Ivanhoe Electric Inc. (the “Company” or “IE”) entered into an Exploration Alliance Agreement (“Agreement”) with Sand Hill Exploration Inc. (a direct wholly-owned subsidiary of the Company) and BHP Mineral Resources Inc. (“BHP")”

Ridgepost Capital, Inc. terminated Rights Agreement with Equiniti Trust Company, LLC (effective 2024-05-08).

“the rights under the Rights Agreement will expire and the Rights Agreement shall terminate at the close of business on May 8, 2024.”

Vintage Wine Estates, Inc. amended Amendment Number One with BMO Bank N.A., as administrative agent and collateral agent, and the Consenting Lenders (effective 2024-05-06).

“On May 6, 2024, the Company, the Borrowers, the Consenting Lenders and the Agent entered into Amendment Number One to the A&R Forbearance Agreement (the “Amendment”).”

Mondee Holdings, Inc. amended Amendment No. 14 with TCW Asset Management Company, Wingspire Capital LLC, and the lenders from time to time party to the Financing Agreement valued at $739,046 (effective 2024-05-07).

“On May 7, 2024, Mondee Holdings, Inc., a Delaware corporation (the “ Company ”), and certain of its subsidiaries, on the one hand, and TCW Asset Management Company, a Delaware limited liability company (the “ Administrative Agent ”), Wingspire Capital LLC, a Delaware limited liability company (“ Wingspire ”), and the lenders from time to time (the “ Lenders ”) party to the Financing Agreement (as defined herein), on the other hand, entered into that certain Amendment No. 14 (the “ Amendment ”) to that certain financing agreement, dated as of December 23, 2019”

Edible Garden AG Inc amended Restated Agreement with Cedar Advance LLC valued at $994,000 (effective 2024-05-03).

“On May 7, 2024, Edible Garden AG Incorporated (the “Company”) entered into an amended and restated standard merchant cash advance agreement (the “Restated Agreement”) with Cedar Advance LLC (“Cedar”), dated as of May 3, 2024, that amends and restates in its entirety, the standard merchant cash advance agreement with Cedar, dated as of March 12, 2024 (the “Agreement”).”

Blue Star Foods Corp. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $2,199,769 (effective 2024-05-03).

“On May 3, 2024, Blue Star Foods, Corp. a Delaware corporation (the “Company”) entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (“Wainwright”), pursuant to which the Company may offer and sell, from time to time through Wainwright, shares of the Company’s common stock, par value $0.0001 per share, for aggregate gross proceeds of up to $2,199,769 (the “Shares”).”

Aditxt, Inc. entered into Securities Purchase Agreement with certain accredited investors (effective 2024-05-02).

“On May 2, 2024, Aditxt, Inc. (the " Company ") entered into a Securities Purchase Agreement (the " Purchase Agreement ") with certain accredited investors”

Fisker Inc./DE amended Amendment No. 1 to the Forbearance Agreement with an institutional investor valued at Amendment No. 1 to the Forbearance Agreement extends forbearance period to May 17, 2024 and amends d (effective 2024-05-01).

“On May 7, 2024, the Obligors and the Investor entered into Amendment No. 1 to the Forbearance Agreement (the “Amendment” and the Forbearance Agreement as amended by such Amendment, the “Amended Forbearance Agreement”), with an effective date as of May 1, 2024, pursuant to which the Investor agreed, subject to the terms set forth in the Amended Forbearance Agreement and among other things, to continue to temporarily forbear from enforcing its right to immediate redemption as demanded in the Event of Default Redemption Notice and from exercising any of its other default-related rights and remedies against the Company and the other Obligors solely with respect to the Specified Defaults, for a period commencing on April 21, 2024 and ending on the earlier of (a) May 17, 2024 and (b) the occurrence of any Forbearance Default (as defined in the Forbearance Agreement).”

Ramaco Resources, Inc. amended First Amendment Agreement with KeyBank National Association, Cadence Bank, Associated Bank, National Association, City National Bank, Star Financial Bank, Trustmark National Bank valued at $275.0 million (effective 2024-05-03).

“On May 3, 2024, Ramaco Resources, Inc. (the “Company”) entered into a First Amendment Agreement (the “First Amendment Agreement”) by and among the (i) the Company, Ramaco Development, LLC, RAM Mining, LLC, Ramaco Coal Sales, LLC, Ramaco Resources, LLC, Ramaco Resources Land Holdings, LLC, Ramaco Coal, Inc., Maben Coal LLC, Carbon Resources Development, Inc., and Ramaco Coal, LLC; (ii) KeyBank National Association, as administrative agent and lender; (iii) Cadence Bank, as lender, (iv) Associated Bank, National Association, as lender; (v) City National Bank, as lender; (v) Star Financial Bank, as lender; and (iv) Trustmark National Bank, as lender.”

NI Holdings, Inc. entered into Stock Purchase Agreement with Scott Insurance Holdings, LLC valued at $10.5 million (effective 2024-05-07).

“On May 7, 2024, NI Holdings, Inc., a North Dakota Corporation (“Seller”), entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”), dated May 7, 2024, between the Seller and Scott Insurance Holdings, LLC, (“Scott Insurance Holdings”) to sell its subsidiary, Westminster American Insurance Company (the “Company”), to Scott Insurance Holdings, a privately owned Maryland limited liability company (“Buyer”), for a cash purchase price of $10.5 million (the “Sale”).”

Lamb Weston Holdings, Inc. terminated Existing Term Loan Credit Agreement.

“The Term Loan Credit Agreement replaces the Company’s existing Credit Agreement, dated as of June 28, 2019 (as amended, the “Existing Term Loan Credit Agreement”)”

Lamb Weston Holdings, Inc. terminated Existing Revolving Credit Agreement.

“The Revolving Credit Agreement replaces the Company’s existing Credit Agreement, dated as of November 9, 2016 (as amended, the “Existing Revolving Credit Agreement”)”

Lamb Weston Holdings, Inc. entered into Amended and Restated Credit Agreement with AgWest Farm Credit, PCA, as administrative agent valued at $325.0 million (effective 2024-05-03).

“On the Closing Date, the Company entered into the Amended and Restated Credit Agreement (the “Term Loan Credit Agreement”), among the Company, as the borrower, the guarantors party thereto, the lenders from time to time party thereto and AgWest Farm Credit, PCA, as administrative agent.”

Lamb Weston Holdings, Inc. entered into Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent valued at $1.5 billion (effective 2024-05-03).

“On May 3, 2024 (the “Closing Date”), Lamb Weston Holdings, Inc. (the “Company”) entered into the Amended and Restated Credit Agreement (the “Revolving Credit Agreement”), among the Company, as a borrower, Lamb-Weston/Meijer v.o.f. (“LW EMEA”), as a borrower, the guarantors party thereto, the lenders from time to time party thereto and Bank of America, N.A., as administrative agent.”

Pathfinder Bancorp, Inc. amended Registration Rights Agreement with Castle Creek Capital Partners VII, L.P. (effective 2024-05-06).

“the Company and Castle Creek agreed to amend the Registration Rights Agreement to allow the Company to file a resale registration statement by no later than May 8, 2025 to register the resale of the securities.”

Hamilton Insurance Group, Ltd. entered into Repurchase Agreement with funds affiliated with Blackstone Alternative Solutions LLC valued at $109,496,748 (effective 2024-05-08).

“On May 8, 2024, Hamilton Insurance Group, Ltd., a Bermuda company (the “Company”), entered into a share purchase agreement (the “Repurchase Agreement”) with funds affiliated with Blackstone Alternative Solutions LLC (“BAS”) pursuant to which the Company has agreed to repurchase 9,124,729 shares of the Company’s Class A common shares owned by such funds at a price per share of $12.00”

NeuroPace Inc amended Amendment with CRG Servicing LLC, as administrative agent and collateral agent for the lenders (effective 2024-05-02).

“On May 2, 2024, NeuroPace, Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Company’s existing Term Loan Agreement, dated as of September 24, 2020 (as amended from time to time, the “Loan Agreement”), with the lenders party to the Loan Agreement and CRG Servicing LLC, as administrative agent and collateral agent for the lenders.”

Karyopharm Therapeutics Inc. entered into Exchange Agreements with a limited number of existing holders of 2025 Notes who are institutional accredited investors and qualified institutional buyers valued at approximately $148.0 million aggregate principal amount (effective 2024-05-08).

“On the Closing Date, the Company also entered into privately-negotiated agreements (the “Exchange Agreements”) with a limited number of existing holders of 2025 Notes who are both institutional “accredited investors” (within the meaning of Rule 501(a)(1), (2), (3) or (7) promulgated under the Securities Act of 1933, as amended (the “Securities Act”)) and “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) (such existing holders, the “Exchange Participants”) to exchange approximately $148.0 million aggregate principal amount of the Exchange Participants’ existing 2025”

Karyopharm Therapeutics Inc. entered into Credit Agreement with the lenders party thereto, and Wilmington Savings Fund Society, FSB, as administrative agent and collateral agent valued at $100.0 million (effective 2024-05-08).

“On May 8, 2024 (the “Closing Date”), the Company entered into a credit and guaranty agreement (the “Credit Agreement”) with the guarantors party thereto, the lenders party thereto (the “Lenders”), and Wilmington Savings Fund Society, FSB, as the administrative agent and collateral agent for the Lenders (in such capacity, the “Term Loan Agent”). The Credit Agreement provides for a senior secured term loan facility of $100.0 million (the “Term Loan”).”

Transocean Ltd. amended Supplemental Indenture with Truist Bank (effective 2024-05-08).

“On May 8, 2024, Transocean Titan Financing Limited (the “Company”), the guarantors named therein and Truist Bank, as trustee and collateral agent, entered into the first supplemental indenture (the “Supplemental Indenture”) to the indenture (the “Indenture”) governing the Company’s 8.375% Senior Secured Notes due 2028 (the “Notes”).”

American National Group Inc. terminated Credit Agreement with Citizens Bank, N.A. (effective 2024-05-07).

“On the Effective Date, the Company repaid in full all indebtedness and other obligations outstanding under, and terminated, the Credit Agreement, dated as of February 15, 2022, among the Company, the lenders party thereto, and Citizens Bank, N.A., as administrative agent.”

American National Group Inc. entered into Term Loan Agreement with Bank of Montreal valued at $1,750,000,000 (effective 2024-05-07).

“On May 7, 2024 (the “ Effective Date ”), American Equity Investment Life Holding Company, an Iowa corporation (the “ Company ”), entered into a new term loan agreement (the “ Term Loan Agreement ”), among the Company, the lenders from time to time party thereto and Bank of Montreal, as administrative agent.”

W. P. Carey Inc. entered into Underwriting Agreement with Merrill Lynch International, Barclays Bank PLC, RBC Europe Limited, Wells Fargo Securities International Limited valued at €650 million aggregate principal amount of 4.250% Senior Notes due 2032 (effective 2024-05-07).

“On May 7, 2024, W. P. Carey Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Merrill Lynch International, Barclays Bank PLC, RBC Europe Limited and Wells Fargo Securities International Limited as representatives of the several underwriters listed in Schedule 1 to the Underwriting Agreement (collectively, the “ Underwriters ”), in connection with the public offering (the “ Offering ”) of €650 million aggregate principal amount of 4.250% Senior Notes due 2032 (the “ Senior Notes ”), issued by the Company.”

AVADEL PHARMACEUTICALS PLC terminated ADS Sales Agreement with Jefferies LLC (effective 2024-05-08).

“The Company terminated the ADS Sales Agreement upon effectiveness of the Sales Agreement following the mandatory exchange of the ADSs and the direct listing of the Ordinary Shares on the Nasdaq Stock Market on April 15, 2024.”

AVADEL PHARMACEUTICALS PLC entered into Open Market Sale Agreement SM with Jefferies LLC valued at up to $100,000,000 (effective 2024-05-08).

“On May 8, 2024, Avadel Pharmaceuticals plc (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (“Jefferies”) pursuant to which the Company may offer and sell its ordinary shares, nominal value $0.01 per share (the “Ordinary Shares”), from time to time, through an “at the market offering” program under which Jefferies will act as sales agent.”

LIFECORE BIOMEDICAL, INC. DE amended Amendment No. 1 with Alcon Research, LLC valued at $5,500,000 (effective 2024-05-02).

“On May 2, 2024, Lifecore Biomedical, LLC, a subsidiary of Lifecore Biomedical, Inc. (the “Company”), entered into Amendment No. 1 (the “ARCMA Amendment”) to Amended and Restated Contract Manufacturing Agreement with Alcon Research, LLC (the “ARCMA”), under which Alcon made a prepayment in the amount of $5,500,000 toward future purchases of products under the ARCMA.”

SONOCO PRODUCTS CO entered into Amended and Restated Credit Agreement with the lenders party thereto valued at $1,250 million revolving credit facility maturing May 3, 2029 (effective 2024-05-03).

“On May 3, 2024, Sonoco Products Company (the “Company”) entered into an Amended and Restated Credit Agreement (the “Agreement”) to extend the maturity and make certain other changes to the terms under the Company’s existing five-year credit agreement dated June 21, 2021.”

LAUREATE EDUCATION, INC. entered into Stock Purchase Agreement with Snow Phipps Group, LLC, Snow Phipps Group, L.P., Snow Phipps Group (B), L.P., Snow Phipps Group (Offshore), L.P., Snow Phipps Group (RPV), L.P. and SPG Co-Investment, L.P. valued at an aggregate purchase price of $30,958,422 (effective 2024-05-06).

“Effective May 6, 2024, Laureate Education, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with each of Snow Phipps Group, LLC, Snow Phipps Group, L.P., Snow Phipps Group (B), L.P., Snow Phipps Group (Offshore), L.P., Snow Phipps Group (RPV), L.P. and SPG Co-Investment, L.P. (each, a “Seller and together, the “Sellers”), pursuant to which the Company agreed to purchase an aggregate of 2,114,928 shares of the Company’s common stock from the Sellers at a purchase price of $14.64 per share for an aggregate purchase price of $30,958,422 (the “Purchase Price”).”